Gas therapy in this review is mediated by hydrogen-releasing nanomaterials. The abstract says it scavenges ROS and regulates the inflammatory microenvironment to exert immunomodulatory effects.
First-pass extracted concept
gas therapy
Extracted Explainers
Evidence Snippets
Gas therapy, mediated by hydrogen-releasing nanomaterials, exerts immunomodulatory effects by scavenging ROS and regulating the inflammatory microenvironment.
Gas therapy, which utilizes the unique properties of gas molecules such as nitric oxide, carbon monoxide, hydrogen, and hydrogen sulfide, is emerging as a promising and innovative strategy to address these challenges.
synergistic multimodal therapies, including chemodynamic therapy, sonodynamic therapy, photothermal therapy, immunotherapy, photodynamic therapy, and gas therapy
Supporting Sources
Linked Claims
Gas therapy has demonstrated significant potential for prevention and treatment of biofilm-associated infections because of unique bioactivity, low resistance, and synergy with existing treatments.
Due to its unique bioactivity, low resistance, and synergy with existing treatments, gas therapy has demonstrated significant potential in the prevention and treatment of biofilm-associated infections.
Future development of gas therapy should prioritize integration of nanotechnology and mechanistic studies.
Future efforts should prioritize the integration of nanotechnology and mechanistic studies to unlock broader therapeutic utility.
Delivery challenges, need for large-scale efficacy validation, and lack of standardized protocols are barriers to clinical translation of gas therapy.
However, overcoming delivery challenges, validating efficacy in large-scale trials, and developing standardized protocols are essential for its clinical translation.
Gas therapy mediated by hydrogen-releasing nanomaterials exerts immunomodulatory effects by scavenging ROS and regulating the inflammatory microenvironment.
Gas therapy, mediated by hydrogen-releasing nanomaterials, exerts immunomodulatory effects by scavenging ROS and regulating the inflammatory microenvironment.
Conventional antibiotic therapies often fail to eradicate biofilms, contributing to persistent infections and clinical challenges.
Conventional antibiotic therapies often fail to eradicate biofilms, which can lead to persistent infections and significant clinical challenges.
Gas therapy is presented as an emerging strategy to address biofilm-associated infection challenges.
Gas therapy, which utilizes the unique properties of gas molecules such as nitric oxide, carbon monoxide, hydrogen, and hydrogen sulfide, is emerging as a promising and innovative strategy to address these challenges.
Micro/nano-motors are described as advantageous for synergistic multimodal tumor therapies including chemodynamic, sonodynamic, photothermal, immunotherapy, photodynamic, and gas therapy.
we discuss the therapeutic mechanisms of MNMs within the tumor microenvironment in detail and highlight the advantages of synergistic multimodal therapies, including chemodynamic therapy, sonodynamic therapy, photothermal therapy, immunotherapy, photodynamic therapy, and gas therapy.